But there are many other medtech stories worth noting from the first quarter of 2017. There was an FDA warning over Abbott’s Absorb bioresorbable stent, a continued spate of M&A deals, diabetes treatment advances including promising study results for Insulet’s Omnipod Horizon hybrid closed-loop system, and much more.
Here are the top medical device stories of early 2017.
